Last reviewed · How we verify
NCT06756412: ExeTMJArthro
The Effects of an Exercise Regimen Following TMJ Arthrocentesis
trial testing Temporomandibular Joint Arthrocentesis in Temporomandibular Joint Disorders in 36 participants. Completed in 16 July 2024.
15 January 2024
Quick facts
| Lead sponsor | Tokat Gaziosmanpasa University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 36 |
| Start date | 8 June 2023 |
| Primary completion | 15 January 2024 |
| Estimated completion | 16 July 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Temporomandibular Joint Arthrocentesis
- Self Exercise Following Arthrocentesis
Conditions studied
- Temporomandibular Joint Disorders — all drugs for Temporomandibular Joint Disorders →
Sponsor
Tokat Gaziosmanpasa University
Who can join
Adults 18 to 65, any sex, with Temporomandibular Joint Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to evaluate the short- and long-term effects of a self-administered exercise program on pain levels, jaw movement range, and jaw function in patients with temporomandibular joint (TMJ) disorders. The main question it aims to answer is: Does adding a self-administered exercise program to arthrocentesis improve pain, mouth opening, and jaw function compared to arthrocentesis alone in patients with TMJ disorders? Participants with acute or chronic TMJ pain lasting at least three months and limited mouth opening will undergo arthrocentesis, with one group also following an exercise regimen. Outcomes will be assessed over a 6-month follow-up period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06756412
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Temporomandibular Joint Arthrocentesis
Trials testing the same drug.
- NCT07479693 — Comparison of Hyaluronic Acid, Injectable Platelet-Rich Fibrin, and Prolotherapy in TMJ Arthrocentesis · NA · completed
Other recruiting trials for Temporomandibular Joint Disorders
Currently open trials in the same condition.
- NCT07317570 — The Effect of Body Awareness Therapy on Pain, Function and Psychosocial Parameters in Temporomandibular Joint Disorders · NA · recruiting
- NCT06763419 — Internal Photobiomodulation For Management Of Temporomandibular Joint Internal Derangement · NA · recruiting
- NCT06721104 — Balance, TMJ, Social Adaptive Assessment in Individuals With Autism Spectrum Disorder · recruiting
- NCT06500390 — Temporomandibular Disorder in Use of Levonorgestrel Intrauterine System · NA · recruiting
- NCT06813040 — Efficacy of Repetitive Transcranial Magnetic Stimulation in Temporomandibular Disorders. · NA · recruiting
Other Tokat Gaziosmanpasa University trials
Trials by the same sponsor.
- NCT07501988 — The Effect Of Color Rotation Technique Training On İnsülin Self-management İn Diabetic Patients. · NA · not yet recruiting
- NCT07154329 — Internet-Based EMDR Flash Intervention for Test Anxiety in University Students · NA · not yet recruiting
- NCT07340866 — Physical Fatigue, Compassion Fatigue, and Quiet Quitting in Physiotherapists · not yet recruiting
- NCT07351617 — Turkish Version of the Pain Metacognitions Questionnaire · not yet recruiting
- NCT07297784 — Impact of Problematic Media Use on Postoperative Pain in Children Undergoing Tonsillectomy · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06756412 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tokat Gaziosmanpasa University
- Last refreshed: 3 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06756412.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing